drugset
drugset / Trial / NCT03757923

Comparison of Metformin and Pioglitazone in Regulating Menstrual Irregularities and Hyperandrogenism

NCT03757923 ↗

Phase 1/2 Unknown 110 enrolled Dow University of Health Sciences
RandomizedParallel-groupOpen-labelTreatment

Summary

To compare metformin with pioglitazone in improving menstrual irregularities and hyperandrogenism in women with PCOS so that an alternate and better treatment option will be available for hyperinsulinemia in pcos patients.

Timeline

Start
2018-06-18
Primary completion
2018-12-17
Completion
2019-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Metformin Small molecule 500 mg —
Subject Pioglitazone Small molecule 30 mg —

Indications

menstrual disorder